GalNAc Ligands / Solid Supports
GalNAc-L96-CPG
Quick view. GalNAc Ligands / Solid Supports-L96-CPG is a GalNAc-L96-functionalized controlled-pore glass support for research-use solid-phase oligonucleotide synthesis. CAS N/A. Catalog target purity: ≥98% (HPLC, calculated as GalNAc-L96-succinate). Availability: Inquiry only — contact OROGO to confirm current availability.
Request a quote Review request checklist
Catalog status
Scope. "Available for inquiry" is not a stock claim. Operating tier is a catalog-merchandising priority. Development phase and program context are shown only where the reviewed catalog source provides a mapping; they describe the chemistry platform and do not claim that OROGO supplies the named program. Annual demand is a planning-model estimate from the reviewed demand dataset, not OROGO sales, inventory, a guaranteed market size or a supply commitment.
| Supply status | Available for inquiry |
|---|---|
| Operating tier | Core |
| Reviewed supporting program count | 5 |
| Representative chemistry-platform program | fitusiran |
| Planning-model annual demand | 630.8 kg/year |
| Demand estimate basis | Planning model: current marketed plus clinical-stage programs |
| Highest development phase | Marketed |
| CAS status | Not published for this exact form |
Product profile
GalNAc-L96-CPG is classified as galnac ligands / solid supports.
GalNAc-L96-CPG — GalNAc-L96-functionalized controlled-pore glass support for research-use solid-phase oligonucleotide synthesis.
For GalNAc-L96-CPG, in-vitro affinity and in-vivo delivery behavior may diverge; valency, linker length and conjugation site need empirical confirmation.
Names and search terms
Confirmed or normalized name variants
- L96-Resin
- L96 GalNAc CPG
Useful catalog search terms
- HR-01006003
- GalNAc controlled-pore glass support
- GalNAc
Physicochemical data
| Support type | GalNAc-L96-functionalized controlled-pore glass |
|---|---|
| Appearance | White to light yellow powder |
| Public assay reference | ≥98% HPLC, calculated as GalNAc-L96-succinate |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Product-specific evaluation notes
Potential advantages
- A defined GalNAc intermediate helps decouple ligand-linker optimization from sequence optimization.
Method limitations
- In-vitro affinity and in-vivo delivery behavior may diverge; valency, linker length and conjugation site need empirical confirmation.
These points describe GalNAc-L96-CPG or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
AdemA-GalNAc Phosphoramidite
GalNAc · CAS: 1953147-02-8
OR-GALN-0005GalNAc-L96 Linker-Acid
GalNAc · CAS: 1426159-34-3
OR-GALN-0007Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine
GalNAc · CAS: 175724-30-8
OR-GALN-0008GalNAc-NAG-37 Phosphoramidite
GalNAc · CAS: 2199491-27-3
OR-GALN-0012Peracetylated GalNAc-L96-Amine
GalNAc · CAS: 1159408-65-7
OR-GALN-0021GalNAc-L96 Succinate Triethylamine Salt
GalNAc · CAS: 1159408-62-4
Product-relevant literature
The publications below discuss named chemistry or a structural feature represented by this product. They provide scientific context only and are not an OROGO lot specification or product-performance claim.
Request a quote Review request checklist
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.